Earnings · China A-shares
Shanghai Kaibao Pharmaceutical Co., Ltd. Class A (300039) earnings
Shanghai Kaibao Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-28: net profit -23.27% year on year, -22.53% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -0.21% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- -23.27%
- Excl. one-offs YoY
- -22.53%
- Net profit QoQ
- +12.17%
- Result
- Bad / loss
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -2.29% | — |
| 3 days | -0.21% | — |
| 7 days | +0.42% | — |
| 14 days | -4.79% | — |
Report history
Over the last 8 reports, net profit grew year on year in 1 of them. The stock rose in the 3 trading days after 2 of 6 reports (average +1.23%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | ¥143.51M | -23.27% | -22.53% | -18.32% | 0.14 | 3.28% | -0.21% | — | — |
| 2026 interim report | 2026-08-25 | ¥101.93M | -16.42% | -17.37% | -23.44% | 0.10 | 2.32% | +12.85% | -1.89% | +4.13% |
| 2026 Q1 report | 2026-04-28 | ¥64.87M | -23.05% | -21.66% | -29.30% | 0.06 | 5.66% | +0.87% | -23.91% | -23.29% |
| 2025 annual report | 2026-04-28 | ¥278.58M | -25.83% | -25.16% | -21.76% | 0.27 | 8.68% | +0.87% | -23.91% | -23.29% |
| 2025 Q3 report | 2025-10-29 | ¥187.04M | -13.83% | -18.47% | -26.95% | 0.18 | 10.79% | +0.00% | +2.11% | +5.58% |
| 2025 interim report | 2025-08-28 | ¥121.95M | -14.20% | -17.81% | -27.08% | 0.12 | 6.31% | -3.07% | -5.83% | -11.33% |
| 2025 Q1 report | 2025-04-16 | ¥84.29M | -4.71% | -6.32% | -15.74% | 0.08 | 2.56% | -3.04% | -1.12% | -3.83% |
| 2024 annual report | 2025-04-16 | ¥375.58M | +14.55% | +21.16% | -7.57% | 0.36 | 4.27% | -3.04% | -1.12% | -3.83% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.